Torrent Group has officially diversified into hospital healthcare with plans for a ₹750 crore, over 500-bed multispecialty hospital in Ahmedabad, marking a strategic expansion beyond its core pharmaceuticals and power businesses. The announcement underscores the group’s vision to build an end-to-end healthcare ecosystem, combining its established strengths in drug manufacturing with direct patient care delivery.

The greenfield project, situated in Ahmedabad’s rapidly developing western corridor, will be developed in phases. Initial beds are expected to become operational by 2027–28, with full capacity rollout following thereafter. The hospital will offer comprehensive tertiary services across key specialties oncology, cardiology, neurosciences, orthopaedics, gastroenterology, nephrology, and critical care supported by advanced diagnostics, modular operation theatres, and intensive care units.

Torrent Group’s entry leverages synergies with Torrent Pharmaceuticals (a top-10 Indian pharma company with strong oncology and cardiology portfolios), enabling integrated research, clinical trials, and personalized treatment pathways. The facility aims to cater to Ahmedabad’s affluent and middle-class segments, competing with established players like Apollo, Sterling, and Zydus while emphasizing quality, transparency, and patient-centric design.

This move aligns with India’s booming hospital sector, driven by rising chronic diseases, medical tourism, and insurance penetration. Torrent’s deep financial resources and land bank in Gujarat provide a solid foundation for scalable, high-standard care.

The project also reflects corporate India’s growing interest in healthcare infrastructure amid post-pandemic priorities for resilient systems.